Brief: Imricor Medical Systems Announces Approval For Commencement Of Visabl-Afl Clinical Trial
18/01/2024 01:16
Jan 18 (Reuters) - Imricor Medical Systems Inc IMR.AX :
* JOHNS HOPKINS HOSPITAL'S INSTITUTIONAL REVIEW BOARD
APPROVED
COMMENCEMENT OF VISABL-AFL CLINICAL TRIAL
Source text for Eikon: ID:nASX6XH2kL
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion